Cargando…
The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014
BACKGROUND: Understanding the burden and clinical presentation of tuberculosis in patients with severe respiratory illness (SRI) has important implications for anticipating treatment requirements. METHODS: Hospitalized patients aged ≥15 years with SRI at 2 public teaching hospitals in periurban area...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570023/ https://www.ncbi.nlm.nih.gov/pubmed/28852676 http://dx.doi.org/10.1093/ofid/ofx116 |
_version_ | 1783259100819226624 |
---|---|
author | Walaza, Sibongile Tempia, Stefano Dreyer, Andries Dawood, Halima Variava, Ebrahim Martinson, Neil A. Moyes, Jocelyn Cohen, Adam L. Wolter, Nicole von Mollendorf, Claire von Gottberg, Anne Haffejee, Sumayya Treurnicht, Florette Hellferscee, Orienka Ismail, Nazir Cohen, Cheryl |
author_facet | Walaza, Sibongile Tempia, Stefano Dreyer, Andries Dawood, Halima Variava, Ebrahim Martinson, Neil A. Moyes, Jocelyn Cohen, Adam L. Wolter, Nicole von Mollendorf, Claire von Gottberg, Anne Haffejee, Sumayya Treurnicht, Florette Hellferscee, Orienka Ismail, Nazir Cohen, Cheryl |
author_sort | Walaza, Sibongile |
collection | PubMed |
description | BACKGROUND: Understanding the burden and clinical presentation of tuberculosis in patients with severe respiratory illness (SRI) has important implications for anticipating treatment requirements. METHODS: Hospitalized patients aged ≥15 years with SRI at 2 public teaching hospitals in periurban areas in 2 provinces (Edendale Hospital in Pietermaritzburg, KwaZulu-Natal Province and Tshepong Hospital in Klerksdorp, North West Province) were enrolled prospectively from 2012 to 2014. Tuberculosis testing included smear microscopy, culture, or Xpert MTB/Rif. RESULTS: We enrolled 2486 individuals with SRI. Of these, 2097 (84%) were tested for tuberculosis, 593 (28%) were positive. Tuberculosis detection rate was 18% (133 of 729) in individuals with acute (≤14 days) presentation and 34% (460 of 1368) in those with chronic (>14 days) presentation. Among laboratory-confirmed tuberculosis cases, those with acute presentation were less likely to present with cough (88% [117 of 133] vs 97% [447 of 460]; ajusted odds ratio [aOR] = 0.2, 95% confidence interval [CI] = 0.1–0.5), night sweats (57% [75 of 132] vs 73% [337 of 459]; aOR = 0.4, 95% CI = 0.3–0.7), or be started on tuberculosis treatment on admission (63% [78 of 124] vs 81% [344 of 423]; aOR = 0.4, 95% CI = 0.3–0.7), but they were more likely to be coinfected with pneumococcus (13% [16 of 124] vs 6% [26 of 411]; aOR 2.3, 95% CI 1.3–5.3) than patients with chronic presentation. Annual incidence of acute and chronic tuberculosis-associated SRI per 100000 population was 28 (95% CI = 22–39) and 116 (95% CI = 104–128), respectively. CONCLUSIONS: In this setting, tuberculosis, including acute presentation, is common in patients hospitalized with SRI. |
format | Online Article Text |
id | pubmed-5570023 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-55700232017-08-29 The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 Walaza, Sibongile Tempia, Stefano Dreyer, Andries Dawood, Halima Variava, Ebrahim Martinson, Neil A. Moyes, Jocelyn Cohen, Adam L. Wolter, Nicole von Mollendorf, Claire von Gottberg, Anne Haffejee, Sumayya Treurnicht, Florette Hellferscee, Orienka Ismail, Nazir Cohen, Cheryl Open Forum Infect Dis Major Article BACKGROUND: Understanding the burden and clinical presentation of tuberculosis in patients with severe respiratory illness (SRI) has important implications for anticipating treatment requirements. METHODS: Hospitalized patients aged ≥15 years with SRI at 2 public teaching hospitals in periurban areas in 2 provinces (Edendale Hospital in Pietermaritzburg, KwaZulu-Natal Province and Tshepong Hospital in Klerksdorp, North West Province) were enrolled prospectively from 2012 to 2014. Tuberculosis testing included smear microscopy, culture, or Xpert MTB/Rif. RESULTS: We enrolled 2486 individuals with SRI. Of these, 2097 (84%) were tested for tuberculosis, 593 (28%) were positive. Tuberculosis detection rate was 18% (133 of 729) in individuals with acute (≤14 days) presentation and 34% (460 of 1368) in those with chronic (>14 days) presentation. Among laboratory-confirmed tuberculosis cases, those with acute presentation were less likely to present with cough (88% [117 of 133] vs 97% [447 of 460]; ajusted odds ratio [aOR] = 0.2, 95% confidence interval [CI] = 0.1–0.5), night sweats (57% [75 of 132] vs 73% [337 of 459]; aOR = 0.4, 95% CI = 0.3–0.7), or be started on tuberculosis treatment on admission (63% [78 of 124] vs 81% [344 of 423]; aOR = 0.4, 95% CI = 0.3–0.7), but they were more likely to be coinfected with pneumococcus (13% [16 of 124] vs 6% [26 of 411]; aOR 2.3, 95% CI 1.3–5.3) than patients with chronic presentation. Annual incidence of acute and chronic tuberculosis-associated SRI per 100000 population was 28 (95% CI = 22–39) and 116 (95% CI = 104–128), respectively. CONCLUSIONS: In this setting, tuberculosis, including acute presentation, is common in patients hospitalized with SRI. Oxford University Press 2017-08-07 /pmc/articles/PMC5570023/ /pubmed/28852676 http://dx.doi.org/10.1093/ofid/ofx116 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Major Article Walaza, Sibongile Tempia, Stefano Dreyer, Andries Dawood, Halima Variava, Ebrahim Martinson, Neil A. Moyes, Jocelyn Cohen, Adam L. Wolter, Nicole von Mollendorf, Claire von Gottberg, Anne Haffejee, Sumayya Treurnicht, Florette Hellferscee, Orienka Ismail, Nazir Cohen, Cheryl The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 |
title | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 |
title_full | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 |
title_fullStr | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 |
title_full_unstemmed | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 |
title_short | The Burden and Clinical Presentation of Pulmonary Tuberculosis in Adults With Severe Respiratory Illness in a High Human Immunodeficiency Virus Prevalence Setting, 2012–2014 |
title_sort | burden and clinical presentation of pulmonary tuberculosis in adults with severe respiratory illness in a high human immunodeficiency virus prevalence setting, 2012–2014 |
topic | Major Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570023/ https://www.ncbi.nlm.nih.gov/pubmed/28852676 http://dx.doi.org/10.1093/ofid/ofx116 |
work_keys_str_mv | AT walazasibongile theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT tempiastefano theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT dreyerandries theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT dawoodhalima theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT variavaebrahim theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT martinsonneila theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT moyesjocelyn theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT cohenadaml theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT wolternicole theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT vonmollendorfclaire theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT vongottberganne theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT haffejeesumayya theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT treurnichtflorette theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT hellfersceeorienka theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT ismailnazir theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT cohencheryl theburdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT walazasibongile burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT tempiastefano burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT dreyerandries burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT dawoodhalima burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT variavaebrahim burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT martinsonneila burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT moyesjocelyn burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT cohenadaml burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT wolternicole burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT vonmollendorfclaire burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT vongottberganne burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT haffejeesumayya burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT treurnichtflorette burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT hellfersceeorienka burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT ismailnazir burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 AT cohencheryl burdenandclinicalpresentationofpulmonarytuberculosisinadultswithsevererespiratoryillnessinahighhumanimmunodeficiencyvirusprevalencesetting20122014 |